Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 129-141 , March 2010

The value of self-monitoring of blood glucose: a review of recent evidence

  • Andrew St John

      Affiliations

    • ARC Consulting, Perth, W Australia 6050, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 9272 4899; fax: +61 8 9272 4899.
    • ,
  • Wendy A. Davis

      Affiliations

    • School of Medicine and Pharmacology, University of Western Australia, Fremantle, W Australia 6160, Australia
    • ,
  • Christopher P. Price

      Affiliations

    • Department of Clinical Biochemistry, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK
    • ,
  • Tim M.E. Davis

      Affiliations

    • School of Medicine and Pharmacology, University of Western Australia, Fremantle, W Australia 6160, Australia

Received 8 May 2008 ,Revised 5 August 2008 ,Accepted 6 January 2009.

References 

  1. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. Journal of Pediatrics. 1997;130:257–265
  2. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technology & Therapeutics. 2007;9:203–210
  3. Bajkowska-Fiedziukiewicz A, Cypryk K, Kozdraj T, Miołajczyk-Swatko A, Kosiński M, Jósefowska M. Self-monitoring of blood glucose and treatment outcomes in type 2 diabetic patients. Polskie Archiwum Medycyny Wewnetrznej. 2008;118:267–272
  4. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel group, 6-month evaluation (DINAMIC 1 study). Diabetes, Obesity and Metabolism. 2008;10:1239–1247
  5. Blonde L, Ginsberg BH, Horn S, Hirsch IB, James B, Mulcahy K, et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2002;25:245–246
  6. Borenstein, M., Hedges, L. V., Higgins, J. P., & Rothstein, H. R. (2005). Comprehensive Meta Analysis™ Version 2. A computer program for research synthesis. Englewood, NJ 07631, USA.
  7. Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet. 2000;356:1844–1847
  8. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Monitoring blood glucose control in diabetes mellitus: A systematic review. Health Technology Assessment. 2000;4:1–93
  9. Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005;28:1531–1533
  10. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: A blinded, randomized trial. American Journal of Medicine. 2005;118:422–425
  11. Davis WA, Bruce DG, Davis TME. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients?. Diabetes Care. 2006;29:1764–1770
  12. Estey AL, Tan MH, Mann K. Follow-up intervention: its effect on compliance behavior to a diabetes regimen. Diabetes Educator. 1990;16:291–295
  13. Evans JM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycemic control: Observational study with diabetes database. British Medical Journal. 1999;319:83–86
  14. Faas A, Schellevis FG, Van Eijk JTM. The efficacy of self-monitoring of blood glucose in NIDDM subjects: A criteria-based literature review. Diabetes Care. 1997;20:1482–1486
  15. Farmer A, Wade A, Goyder E, Yudkin E, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. British Medical Journal. 2007;335:132–136
  16. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, Besse A, et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete & Metabolisme. 1989;15:255–260
  17. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavalieri D, Di Nardo B, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care. 2001;24:1870–1877
  18. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavalieri D, Di Nardo B, et al. Self-monitoring of blood glucose in non-insulin-treated diabetic patients: A longitudinal evaluation of its impact on metabolic control. Diabetic Medicine. 2005;22:900–906
  19. Gray A, Raikou R, McGuire A. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trail (UKPDS 41). British Medical Journal. 2000;320:1373–1378
  20. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, et al. Self- monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabete & Metabolisme. 2003;29:587–594
  21. Harris MI. National Health and Nutrition Examination Survey (NHANES III). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979–982
  22. Heller SR. Self monitoring of blood glucose in type 2 diabetes. British Medical Journal. 2007;335:105–106
  23. Ipp E, Aquino RL, Christenson P. Point: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: The sanguine approach. Diabetes Care. 2005;28:1528–1530
  24. Jaber LA, Halapy H, Fernet M, Tummallapilli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy. 1996;30:238–243
  25. Jansen JP. Self-monitoring of glucose on type 2 diabetes mellitus: A Bayesian meta-analysis of direct and indirect comparisons. Current Medical Research and Opinion. 2006;22:671–681
  26. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi S, Edwards L, et al. Changes in diabetes self-care behaviors make a difference in glycemic control: The diabetes stages of change (DiSC) study. Diabetes Care. 2003;26:732–736
  27. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry. American Journal of Medicine. 2001;111:1–9
  28. Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757–1763
  29. Kwon HS, Cho JH, Kim HS, Lee JH, Song BR, Oh JH, et al. Establishment of blood glucose monitoring system using the internet. Diabetes Care. 2004;27:478–483
  30. Lemozy-Cadroy S, Crognier S, Gourdy P, Chauchard MC, Chale JP, Tauber Dagger JP, et al. Intensified treatment of type 1 diabetes: prospective evaluation at one year of a therapeutic patient education programme. Diabetes & Metabolism. 2002;28:287–294
  31. Lenz M, Steckelberg A, Richter B, Muhlhauser I. Meta-analysis does not allow appraisal of complex interventions in diabetes and hypertension self-management: a methodological review. Diabetologia. 2007;50:1375–1383
  32. Levine B-S, Anderson BJ, Butler DA, Antisdel JA, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. Journal of Pediatrics. 2001;139:197–203
  33. Logan AG. Adherence to self monitoring of blood glucose. Rapid response at: http://www.bmj.com/cgi/eletter-submit/335/7611/132?title=Re%3A+Adherence+to+self-monitoring+of+blood+glucose2008;
  34. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, et al. Self- monitoring of blood glucose in type 2 diabetes and long term outcome: an epidemiological cohort study. Diabetologia. 2006;49:271–278
  35. McAndrew L, Schneider SH, Burns E, Leventhal H. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educator. 2007;33:991–1011
  36. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: What is the evidence?. Diabetes/Metabolism Research and Reviews. 2007;23:423–440
  37. McMurray SD, Johnson G, Davis S, McDougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. American Journal of Kidney Diseases. 2002;40:566–575
  38. Meier JL, Swislocki ALM, Lopez JR. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. American Journal of Managed Care. 2002;8:557–565
  39. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetologica. 1994;31:215–219
  40. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Bokhari SU, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care. 2003;26:1759–1763
  41. National Institute for Clinical Excellence . Management of Type 2 Diabetes — blood glucose (Guideline G). Accessed at: http://www.nice.org.uk/page.aspx?o=367332002;
  42. Nyomba BLG, Berard L, Murphy LJ. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycemic control: A prospective study in insulin-treated diabetic patients. Diabetic Medicine. 2004;21:129–135
  43. O'Kane MJ, Bunting B, Copeland M, Coates VE. ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): Randomized controlled trial). British Medical Journal. 2008;336:1174–1177
  44. Ozmen B, Boyvada S. Can self-monitoring blood glucose control decrease glycated hemoglobin levels in diabetes mellitus. Endocrinologist. 2002;12:349–356
  45. Piette JD, Glasgow RE. Education and home glucose monitoring. In:  Gerstein GC,  Haynes RB editor. Evidence-based diabetes care. Hamilton: B: BC Decker Inc; 2001;p. 207–251
  46. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: A randomized controlled trial. Diabetes Care. 2001;24:202–208
  47. Piette JD, Weinberger M, McPhee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes?. American Journal of Medicine. 2000;108:20–27
  48. Polonsky WH, Earles J, Smith S, Pease DJ, Macmillan M, Christensen R, et al. Integrating medical management with diabetes self-management training: A randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care. 2003;26:3048–3053
  49. Rindone JP, Austin M, Luchesi J. Effect of home blood glucose monitoring on the management of patients with non-insulin dependent diabetes mellitus in the primary care setting. American Journal of Managed Care. 1997;3:1335–1338
  50. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: A meta-analysis (1966–2004). Curr Med Res Opin. 2005;21:173–184
  51. Schiel R, Muller UA, Rauchfub J, Sprott H, Muller R. Blood-glucose self- monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group. Diabetes & Metabolism. 1999;25:334–340
  52. Schiel R, Ulbrich S, Muller UA. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy. Diabetes & Metabolism. 1998;24:509–514
  53. Schutt M, Kern W, Krause U, Busch P, Dapp LM, Grziwotz R, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24500 patients from 191 centers in Germany and Austria. Experimental and Clinical Endocrinology & Diabetes. 2006;114:384–388
  54. Schwedes U, Siebolds M, Mertes G. SMBG Study Group. Meal-related structured self-monitoring of blood glucose: Effect on diabetes control in non-insulin- treated type 2 diabetic patients. Diabetes Care. 2002;5:1928–1932
  55. Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, et al. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Archives of Internal Medicine. 2004;164:645–652
  56. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. British Medical Journal. 2000;321:405–412
  57. Tengblad A, Grodzinsky E, Lindstrom K, Molstad S, Borgquist L, Ostgren CJ. Self-monitoring of blood glucose and glycemic control in type 2 diabetes. Scandinavian Journal of Primary Health Care. 2007;25:140–146
  58. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  59. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. Journal of the American Medical Association. 1996;276:1409–1415
  60. Towfigh A, Romanova M, Weinreb JE, Munjas B, Suttorp MJ, Zhou A, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: A meta-analysis. American Journal of Managed Care. 2008;14:468–475
  61. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853
  62. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. Journal of the American Medical Association. 2001;285:182–189
  63. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: A systematic review. Diabetes Care. 2005;28:1510–1517

PII: S1056-8727(09)00004-X

doi: 10.1016/j.jdiacomp.2009.01.002

Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 129-141 , March 2010

Article Tools

* Image Usage & Resolution